White Blood Cells Flashcards

1
Q

Neutropenia/Agranulocytosis

Pathogenesis (6) Clinical Feature

A

Agranulocytosis is clinically significant neutropenia*

Inadequate Granulopoiesis:
Suppression of stem cells
Drug suppression of precursors (most common)
Ineffective hematopoiesis

Accelerated Destruction:
Immune mediated injury
Splenomegaly (sequestration)
Increased peripheral utilization

Infections causing mucosal ulcerations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Leukocytosis

Etiologies (4) Types with Causes (5)

A

Increased production in marrow (chronic disorders)
Increased release from marrow stores (infection)
Decreased margination (exercise)
Decreased extravasation into tissues (glucocorticoids)

Neutrophilic: Acute bacterial infection, inflammation
Eosinophilic: Allergies, Autoimmune Disorders
Basophilic: myeloproliferative disorders
Monocytosis: Chronic infections
Lymphocytosis: Chronic infections, Viral infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
Lymphadenitis
Acute Etiologies (4)
Chronic Morphology (4)
A

Cervical: Infections of teeth or tonsils
Axillary/Inguinal: Extremity infections
Mesenteric: Acute appendicitis
Generalized: Systemic viral infections and bacteremia

Follicular Hyperplasia (humoral germinal centers)
Tingible Body Macrophages seen between GC's
Paracortical Hyperplasia (T cell response)
Sinus Histiocytosis (sinuses draining cancer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hemophagocytic Lymphohistiocytosis

Pathogenesis (4) Labs (4) Clinical Features (3) Treatment (2)

A

Activation of macrophages and CD8+ CTLs
Macrophages phagocytose bone marrow RBC progenitors
Familial forms caused by decreased degranulation from CTLs and NK cells
Triggered by EBV infection

Elevated Ferritin and IL-2r
Anemia, Thrombocytopenia

Acute febrile illness
Hepatosplenomegaly (hepatitis)
Disseminated Intravascular Coagulation

Treat with immunosuppression and mild chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

White Cell Neoplasias
Etiologic Factors
Mutations (4) Viruses (3) Others (4)

A

Chromosomal translocations:
Help malignant cells proliferate and survive
Create oncoproteins useful for protection and growth
Proto-oncogenes made during receptor rearrangements

Human T cell Leukemia Virus 1 (HTLV-1)
EBV
HHV-8

Smoking (acute myeloid leukemia)
Iatrogenic (radiation/chemo)
Chronic Inflammation (H. pylori)
Inherited Genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Leukemia vs Lymphoma Definitions

A

Leukemia
Neoplasms with widespread involvement of bone marrow and peripheral blood

Lymphoma
Start as discrete tissue masses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Principles of Lymphoid Neoplasms (6)

A

All daughter cells of malignant progenitor share same antigen receptor genes (immunophenotype)

Most cells will appear to be at some point of B/T cell differentiation

Often associated with immune abnormalities

Neoplastic B and T cells will act similar to non-neoplastic

Hodgkin Lymphoma spread orderly
Non-Hodgkin Lymphoma spreads widely and unpredictably

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acute Lymphoblastic Leukemia/Lymphoma
B Cell ALL: Population, Mutations (3), Origin Site
T Cell ALL: Population, Mutation, Origin Site
Prognosis (2) Immunophenotype (3) Lymphoblast Morphology (3)

A

B Cell Acute Leukemia:
Most common cancer of Children**
t(12;21) translocations, RUNX1, ETV6 mutations
Hypercellular Bone marrow: causes pancytopenia

T Cell Acute Lymphoma
Adolescent males
NOTCH1 mutations
Thymus

Aggressive in both cases
Excellent prognosis with aggressive chemotherapy

TdT (+)
CD10/CD19/CD20 (+) (B Cell ALL)
CD1-CD8 (+) (T Cell ALL)

Small amount of cytoplasm
No granules
Condensed Chromatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acute Lymphoblastic Leukemia
Clinical Features (6)
Favorable (5) and Unfavorable (3) Prognostics

A

Abrupt onset of symptoms within weeks:
Anemia, Bleeding
CNS symptoms
Mass Effects: bone pain, General Lymphadenopathy, Hepatosplenomegaly, Testicle Enlargement

Favorable: Age > 2, Low WBC, Hyperdiploidy, Trisomies, t(12;21)

Unfavorable: Age < 2 or adolescent/adult, Peripheral Blasts > 100,000, t(9;22) Philadelphia gene (BCR-ABL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chronic Lymphocytic Leukemia and Small LL

Population (2) Genetics (4) Origin, Immunophenotype (4) Clinical Features (5) Morphology (2)

A
  • CLL and SLL differ only in degree of lymphocytosis
  • CLL is >5000
Most common leukemia in Adults
Older Males (60s)

Deletions: 13q14.3, 11q, 17q
Trisomy 12q

Starts in Lymph Nodes

CD19
CD20
CD23
CD5

Asymptomatic at diagnosis
Small Ig spike present in some patients
Hypogammaglobulinemia 
Hemolytic anemia/Thrombocytopenia
Progression to Diffuse Large B cell Lymphoma (poor prognosis)

Proliferation Centers** (T cell aggregates)
Smudge cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Follicular Lymphoma

Prognosis (2) Origin, Genetics (2) Morphology (3) Immunophenotype (6) Clinical Features (3)

A

Most common indolent non-hodgkin lymphoma
Incurable, survival 7-9 years

Starts in Lymph Nodes

t(14;18) IGH-BCL2 translocation**
MLL2 mutations

Centrocytes (small cleaved cells)
Centroblasts
Peritrabecular lymphoid aggregates in bone marrow

CD10, CD19, CD20
surface Ig
BCL6
BCL2*

Painless generalized lymphadenopathy
Waxing and waning course
Possible histologic transformation to Diffuse Large B cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diffuse Large B Cell Lymphoma
Population, Pathogenesis (2) Morphology (2) Immunophenotype (3) Clinical Features (2) Prognosis (2)
Subtypes (2) with Descriptions (2/2)

A

Most common Non-Hodgkin Lymphoma*

Older males (median age 60)

BCL6 dysregulation
Or BCL2 rearrangements t(14;18)

Diffuse growth pattern
Large cells with round/oval nuclei, appear vesicular

CD19, CD20, surface Ig

Rapidly enlarging mass at nodal/extranodal sites
Waldeyer ring involvement

Aggressive, death if untreated
About half cured with aggressive chemo

Immunodeficiency-associated LBCL:
Associated with HIV
Caused by EBV infection

Primary Effusion Lymphoma:
Pleural/Ascitic effusion associated with HIV
Caused by KSHV/HHV-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Burkitt Lymphoma
Populations (2) Origin, Genetics (2) Morphology (4) Immunophenotype (5) Prognosis (2)
Subtypes: Endemic (3), HIV-Associated, Sporadic (2)

A

Children
Young adults

Germinal centers

Translocation of c-MYC onto Chromosome 8

High mitotic index
Apoptotic cells
Phagocytes with clear cytoplasm (Starry sky pattern)
Blue cytoplasm with multiple nuclei (if in marrow)

CD10, CD19, CD20, IgM, BCL6

Aggressive, fastest growing tumor in humans
Curable with intense chemotherapy

Endemic: EBV associated, jaw mass, involves viscera
HIV-associated: aggressive
Sporadic: mass in illeocecum and peritoneum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Plasma Cell Neoplasms (Dyscrasias)

Most Common, Diagnostic Factors with Descriptions (2) Common Immunophenotype (2)

A

Multiple Myeloma

M Component in blood (monoclonal Ig)
Bence Jones Proteins (free light chains in urine)

CD138 (syndecan-1)
CD56

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Multiple Myeloma

Pathogenesis (3) Morphology (5) Clinical Features (5) Diagnostic Features (3) Genetic Prognostics (4)

A

Rearrangements of the IgH locus - Cyclin D1 mutations
IL-6 keeps myeloma cells alive
MIP1a upregulates RANKL, causes bone resorption

Rouleaux Formation** (red cells stuck together)
Punched out bone lesions** 1-4 cm
Plasmablasts, Flame cells, Mott cells
Inclusions: Fibrils, Crystalline rods
Russell or Dutcher bodies (globular inclusions)

**Multiple Lytic bone lesions (Pathologic Fx)
Hypercalcemia (neuro Sx)
Renal failure (from Bence Jones)
Amyloidosis (from Bence Jones)
**Recurrent bacterial infections (main cause of death)

Bone marrow shows >30% atypical plasma cells
> 3g M proteins in blood (usually IgG or IgA)
> 6g Bence Jones proteins

Cyclin D1 translocations, good
13q, 17p t(4;14), bad

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Solitary Myeloma (Plasmacytoma)
Description and Prognosis
Osseous and Extraosseous

A

Single bone lesion
Inevitably progresses to mutliple myeloma (10-20 years)

Extraosseous lesions often in upper respiratory tract
Cured via excision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
Smoldering Myeloma
Clinical Description (2) and Prognosis
A

Asymptomatic multiple myeloma-like syndrome
Serum M protein greater than 3g

Often progresses to MM over 15 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
Monoclonal Gammopathy of Uncertain Significance
Clinical Description (2) and Prognosis
A

*Most common plasma cell disorder

Asymptomatic multiple myeloma-like syndrome
Serum M protein less than 3g

Per year ~1% of patients develop multiple myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lymphoplasmacytic Lymphoma
Population, Pathogenesis (3) Locations (4) Morphology (2) Immunophenotype (2) Clinical Features (4) Hyperviscosity Syndrome (4)

A

Presents in 60-70s

MYD88 gene mutations
Tumor cells undergo differentiation into plasma cells
Creates mostly monoclonal IgM

Starts in bone marrow
Moves to LNs, liver, spleen

PAS (+) Russell Bodies and Dutcher Bodies

CD20
Surface Ig (usually IgM)

Lymphadenopathy
Hepatosplenomegaly
Anemia
Autoimmune hemolysis by cold agglutinins

Waldenstrom Macroglobulinemia:
Visual impairment (from venous congestion)
Neurologic Problems
Bleeding
Raynaud’s Phenomenon (from cyroglobulinemia)

20
Q

Mantle Cell Lymphoma

Population (2) Genetics (3) Morphology (3) Immunophenotype (4) Clinical Features (2) Prognosis (3)

A

Males in 50s and 60s

t(11;14) translocation of Cyclin D1-IgH locus
Causes Cyclin D1 overexpression

Nodal tumor cells surrounds germinal centers
Homogenous population of small lymphocytes with irregular, deeply clefted nuclear contours
Lymphomatoid Polyposis (GI mucosa involvement)

Cyclin D1
CD19
CD20
CD5

Painless lymphadenopathy
Hepatosplenomegaly

Poor prognosis with no cure
Worst Prognosis: Blastoid variant and Proliferative expression

21
Q
Marginal Zone Lymphomas
Pathologic Description (2), Common Features (3) Pathogenesis (3)
A

B cell lymphomas that arise in LN’s, spleen or extranodal tissues (MALTomas)
After spreading, can transform into diffuse large B cell lymphoma

Arise in areas of Chronic Inflammation
Remain localized for long periods
Regress if inciting inflammation eradicated (H. pylori)

Begins as polyclonal immune reaction
Acquired mutations allow cells to be Ag independent
Mutations upregulate BCL10 or MALT1

22
Q

Hairy Cell Leukemia

Population, Mutation, Morphology, Immunophenotype (4) Clinical Features (4) Prognosis

A

Middle aged (55) white males

Activating BRAF mutations

Cells with fine hair-like projections

CD11c
CD25
CD103
Annexin A1

Splenomegaly
Pancytopenia
Atypical mycobacterial infections
Bone marrow aspiration yields “dry tap”

Mostly indolent, excellent prognosis

23
Q

Peripheral T cell Lymphoma

Morphology (2) Immunophenotype (5) Clinical Features (5) Prognosis

A

Diffusely effaced lymph nodes
Pleomorphic mixture of malignant T cells

CD2, CD4, CD5, CD8
alpha-beta or gamma-delta T cell receptors

Generalized lymphadenopathy
Eosinophilia
Pruritis
Fever
Weight loss

Poor prognosis

24
Q

Anaplastic Large Cell Lymphoma

Mutation (2) Morphology (4) Immunophenotype (2) Prognosis

A

ALK gene rearrangements on Chr 2p23

Hallmark Cells: Anaplastic cells with horseshoe shaped nuclei and voluminous cytoplasm
Cells cluster around venules
Cells infiltrate lymphoid sinuses

ALK (+) cells are diagnostic
CD30

Aggressive but good prognosis

25
Adult T cell Leukemia/Lymphoma | Pathogenesis (2) Morphology (2) Presentation (5) Prognosis (2)
Adults with Human T cell Leukemia Retrovirus-1 (HTLV1) HTLV-1 encodes Tax protein that actives NFKB ``` Multilobated nuclei (cloverleaf/flower cells) CD4+ T cells ``` ``` Skin lesions Generalized lymphadenopathy Hepatosplenomegaly Peripheral blood lymphocytosis Hypercalcemia ``` If only skin, indolent If systemic, rapidly progressive, death within 1 year
26
Mycosis Fungoides and Sezary Syndrome Common Immunophenotype (4) Mycosis: Phases (3) Histology (2) Late Phase (1) Sezary: Presentation, Disease Association (2)
CD4+ T cells CLA adhesion molecule CCR4 CCR10 Mycosis Fungoides: Phases: 1) Premycotic 2) Plaque 3) Tumor Neoplastic T cells in Epidermis and Upper Dermis Cerebriform appearnce to epidermis/dermis Late phase spread to lymph nodes and bone marrow Sezary Syndrome: Generalized exfoliative erythroderma Leukemia with Sezary cells showing cerebriform nuclei
27
Large Granular Lymphocytic Leukemia | Mutation, Morphology (3) Immunophenotype (2) Clinical Features (2) Associated Syndrome (3)
STAT3 mutations Either T cells or NK cells Large lymphocytes with abundant blue cytoplasm Coarse azurophilic granules CD3 (T cells) CD56 (NK cells) Neutropenia Anemia Felty Syndrome: Rheumatoid arthritis, Splenomegaly, Neutropenia
28
Extranodal NK/T cell Lymphoma | Pathogenesis, Morphology (3) Presentation (2) Prognosis
Highly associated with EBV** Cell infiltrate surrounds small vessels, ischemic necrosis Large azurophilic granules Mostly NK cells, less T cells Destructive nasopharyngeal mass** Or mass in testes/skin Aggressive, responds well to radiation (no chemo)
29
Hodgkin Lymphomas | Populations (2) Origin/Spread (3) Pathogenesis (3) Prognosis
Most common cancer of teenagers Usually presents in 30s Arises in Lymph Nodes Spreads to contiguous lymphoid tissues Spreads to Spleen, then Liver, then Bone marrow Activation of NFKB via: EBV (cells express LMP-1) IkB or A20 (TNFAIP3) mutations Good prognosis with radiation therapy
30
``` Hodgkin Lymphomas Characteristic Morphology (2) with Common Variants (3) Immunophenotype (3) Clinical Features (3) ```
Reed Sternberg Cells: Multinucleated giant cells with inclusion-like nucleoli Variants: Mononuclear, Lacunar cells, Lymphohistiocytic PAX5 CD15 CD30 Painless Lymphadenopathy Fever, night sweats, weight loss (disseminated disease) Cutaneous immune anergy
31
Hodgkin Lymphoma Subtypes Nodular Sclerosis Type Pathogenenesis, Locations (2) and Morphology (3)
Most common Not usually EBV associated Starts in Lower Cervical and Supraclavicular LN's Lacunar cells Few Reed Sternberg Cells Deposition of collagen that divides up lymph nodes
32
Hodgkin Lymphoma Subtypes Mixed Cell Type Population, Morphology, Clinical Feature, Prognosis
Older Males Plentiful Reed Sternberg cells Presents with Advanced tumor Very good prognosis
33
``` Hodgkin Lymphoma Subtypes Lymphocyte Rich Type Cells Involved (3) Clinical Features (2) ```
Reactive Lymphocytes Mononuclear cells Reed Sternberg cells Often EBV associated Good Prognosis
34
Hodgkin Lymphoma Subtypes Lymphocyte Depletion Type Populations (2) Cells Involved, Pathogenesis, Prognosis
Least common Older adults HIV (+) people Reed Sternberg cells and their subtypes EBV associated 90% of time Least favorable prognosis
35
Hodgkin Lymphoma Subtypes Lymphocyte Predominance Type Population (2) Morphology (3) Immunophenotype (2) Clinical Features (3)
*Non-Classical HL Males under 35 ``` Lymphocytic and Histiocytic variant cells Multilobed nuclei (popcorn kernel cells) Expanded B cell follicles (nodular growth) ``` CD20 BCL6 Cerivcal and Axillary lymphadenopathy Can transform into Diffuse Large B cell lymphoma NOT EBV associated
36
``` Acute Myeloid Leukemia Major Subtypes (3) with Prognoses Genetic Aberrations (4) Pathogenesis (2) Causal Therapies (3) ```
AML with Genetic Aberrations: mostly good prognosis AML with MDS-like Features: poor prognosis Therapy-related AML: worst prognosis t(8;21) RUNX1/ETO fusion* inv(16) CBFB/MYH11 fusion* t(15;17) RARA/PML fusion (best prognosis) Karytotypic aberrations Mutations of transcription factors of myeloid differentiation Epigenetic alterations After alkylator, radiation or anti-Topoisomerase II therapy
37
Acute Myeloid Leukemia | Diagnosis, Morphology (3) Immunophenotype (2) Clinical Features (6)
Requires bone marrow biopsy showing at least 20% myeloid blasts Myeloblasts with peroxidase (+) azurophilic granules Auer rod granules Monoblasts that are esterase (+) CD33 and CD34 Anemia: fatigue Neutropenia: fever Thrombocytopenia: Bleeding, bruising, Petechiae Opportunistic infections Tissue Infiltration: Leukemia cutis (monocytic differentiation) Granulocytic sarcoma
38
Myelodysplastic syndromes | Etiologies (2) Mutations (4) Morphology (6) Clinical Features (3)
Primary - idiopathic Secondary - genotoxic drugs or radiation Similar epigenetic factors to AML Mutations involving RNA splicing factors Transcription factor mutations TP53 mutations Myeloblasts < 20% Megaloblasts Ring sideroblasts Nuclear budding abnormalities: misshapen outlines Pseudo Pelger Huet cells (bilobed neutrophils) Pawn ball megakaryocytes Mean age 70 Pancytopenia Progression to AML
39
``` Myeloproliferative Disorders Common Pathogenesis (2) Common Clinical Description (4) ```
Mutated, constitutively activated Tyrosine Kinases Cause growth factor independence Increased bone marrow proliferation Increased extramedullary hematopoiesis Spent phase: marrow fibrosis, peripheral cytopenias Transformation to acute leukemia
40
Chronic Myelogenous Leukemia | Population, Genetics (4) Origin, Morphology, Diagnosis (3) Clinical Features (4)
Adult males Philadelphia Chromosome (9;22)(q34;q11) BCR-ABL fusion gene Constitutively activated ABL tyrosin kinase Originates from pluripotent HSC's Macrophages with wrinkled green-blue cytoplasm Hypercellular marrow Leukocytosis Decreased Leukocyte Alkaline Phosphatase (LAP) Insidious onset: mild anemia Splenomegaly: abdominal fullness or pain Hepatomegaly, lymphadenopathy Blast crisis during late accelerated phase
41
Polycythemia Vera | Mutation (2) Morphology (2) Labs (5) Presentation (5) Treatment
Activating JAK2 point mutation Causes upregulated RBC production Increased red cell, granulocyte and megakaryocyte precursors Spent phase: marrow fibrosis ``` Low EPO Elevated HCT Increased Red Cell Mass (hyperviscous blood) Leukocytosis Thrombocytosis ``` ``` Major bleeding episodes* Venous thrombosis* Hyperuricemia Spent stage May progress to AML ``` Treat with phlebotomy
42
Essential Thrombocytosis | Mutations (2) Labs, Morphology, Diagnosis, Clinical Features (3) Treatment
Activating mutations in JAK2 Activating mutations in MPL Isolated elevated platelet count (thrombocytosis) Large platelets Elevated megakaryocyte count on bone marrow biopsy Erythromelalgia (burn/throb of hands/feet) Bleeding Thrombosis Gentle chemo to stop thrombopoiesis
43
Primary Myelofibrosis | Mutations (2) Pathogenesis (2) Clinical Features (2) Blood Smear (2) Prognosis (2)
Activating mutations in JAK2 Activating mutations in MPL Obliterative bone marrow fibrosis via non-neoplastic fibroblasts making collagen Caused by PDGF and TGF-Beta from megakaryocytes Normochomic normocytic Anemia Prominent splenomegaly Tear drop shaped RBC's (dacrocytes)* Leukoerythroblastosis* Poor prognosis, hard to treat Death via infections, bleeding abnormalities
44
Langerhans Cell Histiocytosis | Mutation, Common Morphology (2) Common Immunophenotype (2)
BRAF point mutation Val-Glu ``` Birbeck granules (pentalaminar tubules) Abundant cytoplasm, nuclei with linear grooves ``` CCR6 CCR7
45
``` Multifocal Langerhans Cell Histiocytosis (Letterer-Siwe) Clinical Features (7) Prognosis ```
``` Seborrheic eruption cutaneous lesions Chronic ottitis media Mastoiditis Hepatosplenomegaly Lymphadenopathy Lung lesions Bone lesions ``` Rapidly fatal if untreated (50% survive if treated)
46
Uni/Multifocal Unisystem Langerhans Cell Histiocytosis (Eosinophilic Granuloma) Morphology (2) Origin (3) Unifocal Clinical Description (2) Multifocal Clinical Description (5)
Langerhans cells mixed with eosinophils, lymphocytes, plasma cells, and neutrophils Arises in medullary cavity of calvarium, ribs, femur Unifocal painful bone lesions Indolent, may resolve spontaneously or with excision Multifocal erosive painful bone lesions Presents in young children Hand-Schuller-Christian Triad: Diabetes Insipidus, Exopthalmus, Calvarium defects
47
Pulmonary Langerhans Cell Histiocytosis | Etiologies (2)
Chronic smoking | BRAF mutations